Estrogenic phenol and catechol metabolites of PCBs modulate catechol-o-methyltransferase expression via the estrogen receptor: Potential contribution to cancer risk

Current Drug Metabolism

Volumn 9, Issue 4, 2008, Pages 304-309

  Ho, P W L ^a   Garner, C E ^c   Ho, J W M ^a   Leung, K C ^a   Chu, A C Y ^a   Kwok, K H H ^a   Kung, M H W ^a   Burka, L T ^b   Ramsden, D B ^d   Ho, S L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^c ASTRAZENECA   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Carcinogenesis; COMT; Estrogen; PCB; Xenobiotic catechols

Indexed keywords

2',4' DICHLOROBIPHENYL 4 OL; 2',4',5' DICHLOROBIPHENYL 3,4 DIOL; 2',4',6' DICHLOROBIPHENYL 3,4 DIOL; 2',4',6' DICHLOROBIPHENYL 4 OL; 2',5' DICHLOROBIPHENYL 2 OL; 2',5' DICHLOROBIPHENYL 2,3 DIOL; 2',5' DICHLOROBIPHENYL 3,4 DIOL; 2',5' DICHLOROBIPHENYL 4 OL; 2,5 DICHLOROBIPHENYL; ACTIN; BIPHENYL DERIVATIVE; CATECHOL METHYLTRANSFERASE; ESTRADIOL; ESTROGEN RECEPTOR; FULVESTRANT; ORGANOCHLORINE DERIVATIVE; POLYCHLORINATED BIPHENYL DERIVATIVE;

CANCER RISK; CELL STRAIN MCF 7; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; REVIEW; WESTERN BLOTTING;

ACTINS; BLOTTING, WESTERN; CATECHOL O-METHYLTRANSFERASE; CATECHOLS; CELL LINE, TUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; HUMANS; NEOPLASMS; PHENOLS; POLYCHLORINATED BIPHENYLS; RECEPTORS, ESTROGEN; RISK;

EID: 45249092256     PISSN: 13892002     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920008784220600     Document Type: Review

References (46)

1. WHO. Environmental Health Criteria 140: Polychlorinated Biphenyls and Terphenyls-2nd Ed. World Health Organization, Geneva. 1993.
2. Fox, G.A. (1992) in Chemically-induced alterations in sexual and functional development: the wildlife/human connection. (Colborn, T. & Clement, C.) Princeton Scientific Publishing, New Jersey, p147-158.
3. Fuller, G.; Hobson, W. (1986) in PCBs and the Environment, vol. II. (Waid, J.) CRC Press, Boca Raton, Florida, pp. 101-127.
4. Harding, G.C.; Addison, R.F. (1986) in PCBs and the Environment, vol. II. (Waid, J.) CRC Press, Boca Raton. Florida, pp. 9-30.
5. LeBlanc, G.A. (1995) Environ. Health Perspect., 103, 888-890.
6. Hileman, B. (1994) Chem Eng. News, 72, 19-23.
7. Heaton, S.N.; Bursian, S.J.; Giesy, J.P.; Tillitt, D.E.; Render, J.A.; Jones, P.D.; Verbrugge, D.A.; Kubiak, T.J. and Aulerich, R.J. (1995) Arch Environ. Contam. Toxicol., 28, 334-343.
8. Segura-Aguilar, J.; Castro, V. and Bergman A. (1997) Biochem Mol. Med., 60, 149-154.
9. Mayes, B.A.; McConnell, E.E.; Neal, B.H.; Brunner, M.J.; Hamilton, S.B.; Sullivan, T.M.; Peters, A.C.; Ryan, M.J.; Toft, J.D.; Singer, A.W.; Brown, J.F. Jr.; Menton, R.G. and Moore, J.A. (1998) Toxicol. Sci., 41, 62-76.
10. Freeman, G.B.; Lordo, R.A.; Singer, A.W.; Peters, A.C.; Neal, B.H.; McConnell, E.E. and Mayes, B.A. (2000) Toxicol. Sci., 53, 377-391.
11. Ball, P. and Knuppen, R. (1980) Acta Endocrinologica, (Suppl 232), 93, 1-125.
12. Yager, J.D. and Liehr, J.G. (1996) Annu. Rev. Pharmacol. Toxicol., 36, 203-232.
13. Cavalieri, E.L. and Rogan, E.G. (1998) Adv. Pharmacol., 42, 837-840.
14. Stack, D.E.; Cavalieri, E.L. and Rogan, E.G. (1998) Adv. Pharmacol., 42, 833-836.
15. Weisz, J.; Clawson, G.A. and Creveling, C.R. (1998) Adv. Pharmacol., 42, 828-833.
16. Liehr, J.G. (1998) Adv. Pharmacol., 42, 824-828.
17. Cavalieri, E.L.; Stack, D.E., Devanesan, P.D.; Todorovic, R.; Dwivedy, I.; Higginbotham, S.; Johansson, S.L.; Patil, K.D.; Gross, M.L.; Gooden, J.K.; Ramanathan, R.; Cerny, R.L. and Rogan, E.G. (1997) PNAS, 94, 10937-10942.
18. Stack, D.E.; Byun, J.; Gross, M.L.; Rogan, E.G and Cavalieri EL. (1996) Chem. Res. Toxicol., 9, 851-859.
19. Li, J.J. and Li, S.A. (1984) Arch. Toxicol., 55, 110-118.
20. Seraj, J.S.; Umemoto, A.; Tanaka, M.; Kajikawa, A.; Hamada, K. and Monden, Y. (1996) Mutat. Res., 370, 49-59.
21. Ashburn, S.P.; Han, X. and Liehr, J.G. (1993) Mol. Pharmacol., 43, 534-541.
22. Liehr, J.G. (1997) Eur. J. Cancer Prev., 6, 3-10.
23. Han, X. and Liehr, J.G. (1995) Carcinogenesis, 16, 2571-2574.
24. Liehr, J.G.; Ulubelen, A.A. and Strobel, H.W. (1986) J. Biol. Chem., 261, 16865-16870.
25. Garner, C.E.; Jefferson, W.N.; Burka, L.T.; Matthews, H.B. and Newbold, R.R. (1999) Toxicol. Appl. Pharmacol., 154, 188-197.
26. Connor, K.; Ramamoorthy, K.; Moore, M.; Mustain, M.; Chen, I.; Safe, S.; Zacharewski, T.; Gillesby, B.; Joyeux, A. and Balaguer, P. (1997) Toxicol. Appl. Pharmacol., 145, 111-123.
27. Ramamoorthy, K.; Vyhlidal, C.; Wang, F.; Chen, I.; Safe, S.; McDonnell, D.P.; Leonard, L.S. and Gaido, K.W. (1997) Toxicol. Appl. Pharmacol., 147, 93-100.
28. Jansen HT, Cooke PS, Porcelli J, Liu, T.C. and Hansen, I., G. (1993) Reprod. Toxicol., 7, 237-248.
29. Korach, K.S.; Sarver, P.; Chae, K.; McLachlan, J.A.and McKinney, J.D. (1988) Mol. Pharmacol., 33, 120-126.
30. Korach, K.S.; Davis, V.D.; Curtis, S.W. and Bocchifuso, W.P. (1997) in Endocrine Toxicology. (Thomas, J.A. & Colby, H.D.) Taylor and Francis, Washington, DC. p181-213.
31. Fielden, M.R.; Chen, I.; Chittim, B.; Safe, S.H. and Zacharewski, T.R. (1997) Environ. Health Perspect., 105, 1238-1248.
32. Garner, C.E.; Burka, L.T.; Etheridge, A.E. and Matthews, H.B. (2000a) Toxicol. Appl. Pharmacol., 162, 115-123.
33. Garner, C.E.; Matthews, H.B. and Burka, L.T. (2000b) Toxicol. Appl. Pharmacol., 162, 124-131.
34. Zhu, B.T. and Liehr, J.C. (1996) J. Biol. Chem., 271, 1357-1363.
35. Zhu, B.T. and Liehr, J.C. (1994) Toxicol. Appl. Pharmacol., 125, 49-158.
36. Xie, T.; Ho, S.L. and Ramsden, D.B. (1999) Mol. Pharmacol., 56, 31-38.
37. Jiang, H.; Xie, T.; Ramsden, D.B. and Ho, S.L. (2003) Neuropharmacology, 45, 1011-1018.
38. Karege, F., Bovier, P., Gaillard, J.M., and Tissot, R. (1987) Acta Psychiatrica Scandinavica, 76, 303-308.
39. Bradford, M.M. (1976) Anal. Biochem., 72, 248-254.
40. Lachman, H.M.; Papolos, D.F., Saito, T.; Yu, Y.M.; Szumlanski, C.L. and Weinshilboum, R.M. (1996) Pharmacogenetics, 6, 243-250.
41. Thompson, P.A.; Shields, P.G.; Freudenheim, J.L.; Stone, A.; Vena, J.E.; Marshall, J.R.; Graham, S.; Laughlin, R.; Nemoto, T.; Kadlubar, F.F. and Ambrosone, C.B. (1998) Cancer Res., 58, 2107-2110.
42. Millikan, R.C.; Pittman, G.S.; Tse, C.K.; Duel, E.; Newman, B.; Savitz, D.; Moorman, P.G.; Boissy, R.J. and Bell, D.A. (1998) Carcinogenesis (Lond.), 19, 1943-1947.
43. Lavigne, J.A.; Helzlsouer, K.J.; Huang, H.Y.; Strickland, P.T.; Bell, D.A.; Selmin, O.; Watson, M.A.; Hoffinan, S.; Comstock, G.W. and Yager, J.D. (1997) Cancer Res., 57, 5493-5497.
44. Huang, C.; Chem, H.; Chang, K.; Cheng, C.W.; Hsu, S.M. and Shen, C.Y. (1999) Cancer Res., 59, 4870-4875.
45. Matsui, A.; Ikeda, T.; Enomoto, K.; Nakashima, H.; Omae, K.; Watanabe, M.; Hibi, T. and Kitajima, M. (2000) Cancer Lett., 150, 23-31.
46. Martone, T.; Vineis, P.; Malavielle, C. and Terracini, B. (2000) Mutat. Res., 462, 303-309.